Protara Therapeutics, Inc. - Common Stock financial statements
Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.
Filed statements
| USD; millions except EPS | Jun 2026Filed 11/08/2026 | Mar 2026Filed 11/08/2026 | Sep 2025Filed 10/11/2025 | Jun 2025Filed 11/08/2026 | Mar 2025Filed 11/08/2026 | Sep 2024Filed 10/11/2025 | Jun 2024Filed 10/11/2025 | Mar 2024Filed 10/11/2025 |
|---|---|---|---|---|---|---|---|---|
| −$22 | −$18 | −$13 | −$15 | −$12 | −$11 | −$9.5 | −$11 | |
| −$0.36 | −$0.31 | −$0.31 | −$0.35 | −$0.29 | −$0.50 | −$0.45 | −$0.97 | |
| 61 | 58 | 42 | 42 | 41 | 22 | 21 | 11 |
Trend